STOCK TITAN

Bioventus to Present at the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Bioventus Inc. (Nasdaq: BVS) announced that CEO Ken Reali will present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023, at 5:15 p.m. PT (8:15 p.m. ET). The presentation will be live-streamed and accessible via the Bioventus Investors webpage, remaining available until February 10, 2023.

Bioventus focuses on delivering innovative, clinically proven products for active healing, including pain treatments and surgical solutions, emphasizing quality and ethical practices.

Positive
  • None.
Negative
  • None.

DURHAM, N.C., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Ken Reali, chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 5:15 p.m. PT (8:15 p.m. ET).

The live webcast of the presentation, including Q&A, may be accessed on the Investors section of the Bioventus website and will be available until February 10, 2023.

About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Investor and Media Inquiries:
Dave Crawford
919-474-6787
dave.crawford@bioventus.com


FAQ

What is the date and time of Bioventus' presentation at the J.P. Morgan Healthcare Conference?

Bioventus will present on January 11, 2023, at 5:15 p.m. PT (8:15 p.m. ET).

How can investors access the Bioventus presentation at the 41st Annual J.P. Morgan Healthcare Conference?

The presentation will be available live on the Bioventus Investors section of their website.

Until when will the Bioventus presentation be available for viewing?

The webcast will be accessible until February 10, 2023.

What is the focus of Bioventus' products?

Bioventus specializes in clinically proven, cost-effective products for pain treatments, restorative therapies, and surgical solutions.

What stock symbol represents Bioventus?

The stock symbol for Bioventus is BVS.

Bioventus Inc.

NASDAQ:BVS

BVS Rankings

BVS Latest News

BVS Stock Data

750.42M
57.83M
11.48%
69.76%
2.05%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
DURHAM